*NOTE: This section includes amendments by temporary legislation that will expire on December 29, 2022. To view the text of this section after the expiration of all emergency and temporary legislation, click this link: Permanent Version.*
*NOTE: This section includes amendments by emergency legislation that will expire on January 15, 2023. To view the text of this section after the expiration of all emergency and temporary legislation affecting this section, click this link: Permanent Version.*
(a) The Boards of Medicine, Nursing, and Dentistry" shall have the authority to review and audit the written authorized practitioner recommendations submitted to ABRA as part of the registration process and shall have the authority to discipline authorized practitioners under their licensing authority who act outside of the scope of this chapter.
(b) Repealed.
(c) Submitting a false statement regarding a qualifying patient’s eligibility to participate in the Program on the form developed pursuant to § 7-1671.04(b)(2) shall be grounds for the revocation, suspension, or denial of an authorized practitioner's license, or the imposition of a civil fine pursuant to § 3-1205.14(c), or both, at the licensing board's discretion.
(Feb. 25, 2010, D.C. Law 13-315, § 8; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(g), 63 DCR 15291; Dec. 3, 2020, D.C. Law 23-149, § 5012(f), 67 DCR 10493; May 18, 2022, D.C. Law 24-122, § 2(d), 69 DCR 002670; Oct. 17, 2022, D.C. Act 24-565, § 2(e), 0 DCR 0.)
This section is referenced in § 3-1202.03 and § 7-1671.04.
For temporary (90 days) amendment of this section, see § 2(e) of Medical Marijuana Patient Access Extension Second Emergency Amendment Act of 2022 (D.C. Act 24-565, Oct. 17, 2022, 0 DCR 0).
For temporary (90 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Extension Congressional Review Emergency Amendment Act of 2022 (D.C. Act 24-400, May 9, 2022, 0 DCR 0).
For temporary (90 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 (D.C. Act 24-323, Feb. 11, 2022, 69 DCR 001268).
For temporary (90 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Emergency Amendment Act of 2021 (D.C. Act 24-206, Nov. 5, 2021, 68 DCR 012188).
For temporary (225 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Extension Temporary Amendment Act of 2022 (D.C. Law 24-122, May 18, 2022, 69 DCR 002670).
For temporary (225 days) amendment of this section, see § 2(d) of Medical Marijuana Patient Access Temporary Amendment Act of 2021 (D.C. Law 24-78, Feb. 24, 2022, 69 DCR 000204).
Structure District of Columbia Code
Title 7 - Human Health Care and Safety
Chapter 16B - Use of Marijuana for Medical Treatment
§ 7–1671.02. Use of medical marijuana
§ 7–1671.03. Restrictions on use of medical marijuana
§ 7–1671.04. Recommending authorize practitioner; protections
§ 7–1671.05. Medical marijuana program
§ 7–1671.06. Dispensaries and cultivation centers
§ 7–1671.08a. Medical Cannabis Administration Fund
§ 7–1671.08b. Medical Cannabis Social Equity Fund
§ 7–1671.09. Medical Marijuana Advisory Committee